Kajal Sharma, Swati Agrawal, Ratna Biswas, Muntaha Khan, Ira Arora, Adeeba Saman and Monika
Endometriosis affects roughly 10% (190 million) of repro- ductive age women and girls globally. It is a chronic disease associated with severe, life-impacting pain during periods, sexual intercourse, bowel movements and/or urination, chronic pelvic pain, abdominal bloating, nausea, fatigue, and sometimes depression, anxiety, and infertility. Access to early diagnosis and effective treatment of endometriosis is important, but is limited in many settings, including in low- and middle-income countries [1].